How Lundbeck’s CEO aims to keep firm ‘punching above its weight’
Almost three years into his tenure as Lundbeck’s CEO, Charl van Zyl is confident the company can prove…
R&D budget surges 107-fold over past decade
ANKARA Türkiye’s budget allocations for R&D for space exploration activities rise from 13.2 billion Turkish Liras to 309…
China overtakes US to lead global R&D spending, hitting $615bn
Science Corporate, university expenditures for 2024 include computers, electronics China’s jump in R&D spending was driven by corporate…
The data that led Cellular Intelligence to pick up Novo’s Parkinson’s stem cell therapy
MONTREAL — After Novo Nordisk closed its cell therapy unit, Cellular Intelligence contracted neurologist and drug developer Nuno…
Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks – Endpoints News
Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks Endpoints NewsNature retracts provocative PD-1…
Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals – Endpoints News
Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals Endpoints NewsCompass Pathways to Announce New…
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints News
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial Endpoints NewsRoche unveils data behind BTK inhibitor’s phase 3…
Open Questions | Lawrence Lau on why China must ‘work smarter’ and how it can invent from scratch
Lawrence J. Lau is a Hong Kong economist specialising in economic development and East Asian economies. He was…
Exclusive: In major test for longevity field, FDA greenlights study on a 'near total reset' of cells – Endpoints News
Exclusive: In major test for longevity field, FDA greenlights study on a ‘near total reset’ of cells Endpoints NewsScientists…
AI tech, personalized solutions, and nutrition security in the GLP-1 era
As we prepare to turn the page on the year, Nutrition Insight revisits some of the most significant…
Genetic Testing Enables Tailored Treatments, Better Outcomes
Q: What solutions does OncoAtlas bring to patients and health professionals? A: OncoAtlas is a science-based company that…
Last call for European startups: Your fast track into Japan’s $165 billion R&D market (Sponsored)
Japan is the world’s third-largest economy and a global leader in robotics, advanced manufacturing, and healthcare technology. However,…